Insider Shareholders with Direct Ownership of Edgewise Therapeutics, Inc. (EWTX)
This section provides a comprehensive overview of the insiders with direct ownership of Edgewise Therapeutics, Inc. (EWTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Edgewise Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
6,071,703 | 0 | 6,071,703 $155 Million | 2 |
Sep 14, 2022
Added 7.39%
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
681,812 | 0 | 681,812 $17.4 Million | 1 |
Mar 30, 2021
Added 50.0%
|
|
R Michael Carruthers
Chief Financial Officer |
285,484 | 218,585 | 76,904 $1.96 Million | 11 |
Oct 11, 2024
Added 47.65%
|
|
Behrad Derakhshan
Chief Business Officer |
72,484 | 65,533 | 16,837 $429,848 | 14 |
Feb 05, 2025
Reduced 37.26%
|
| 45,833 | 39,098 | 16,358 $417,619 | 7 |
Jan 28, 2025
Reduced 60.45%
|
|
| 15,625 | 0 | 15,625 $398,906 | 1 |
Mar 30, 2021
Added 50.0%
|
|
|
Alan J Russell
Chief Scientific Officer |
367,216 | 624,078 | 14,863 $379,452 | 39 |
Feb 06, 2025
Reduced 7.47%
|
|
Kevin Koch
President and CEO |
30,369 | 15,891 | 14,478 $369,623 | 8 |
Feb 06, 2025
Reduced 5.85%
|
| 10,857 | 0 | 10,857 $277,179 | 1 |
Dec 26, 2023
Added 50.0%
|
|
|
Marc Semigran
Chief Development Officer |
29,709 | 29,709 | 6,716 $171,459 | 2 |
Dec 24, 2024
Reduced 20.47%
|
|
John R Moore
General Counsel |
318,798 | 320,732 | 3,252 $83,023 | 52 |
Sep 23, 2024
Reduced 86.55%
|